Bernard De Bruyne

Showing 1-20 of 31 articles

Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system

Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa R, Chamié D, de Ribamar Costa J, Kereiakes D, Abizaid A, Colombo A

December 18, 2020 | 10.4244/EIJ-D-20-00763

Coronary interventions

Normal Values of Thermodilution-Derived Absolute Coronary Blood Flow and Microvascular Resistance in Humans

Fournier S, Keulards DC, van ‘t Veer M, Colaiori I, Di Gioia G, Zimmermann FM, Mizukami T, Nagumo S, Kodeboina M, El Farissi M, Zelis JM, Sonck J, Collet C, Pijls N, De Bruyne B

October 6, 2020 | 10.4244/EIJ-D-20-00684

Steady-state hyperaemia: many routes, one goal

Toth G, De Bruyne B

September 18, 2020 | 10.4244/EIJV16I7A98

Coronary interventions

Deep Learning For Prediction of Fractional Flow Reserve From Resting Coronary Pressure Curves (ARTIST study)

Zimmermann FM, Mast TP, Johnson N, Everts I, Hennigan B, Berry C, Johnson DT, De Bruyne B, Fearon W, Oldroyd K, Pijls N, Tonino P, van 't Veer M

September 1, 2020 | 10.4244/EIJ-D-20-00648

Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: the PROACTIVE trial

Pellicano M, Di Gioia G, Ciccarelli G, Xaplanteris P, Delrue L, Toth G, Van Durme F, Heyse A, Wyffels E, Vanderheyden M, Bartunek J, De Bruyne B, Barbato E

June 12, 2020 | 10.4244/EIJ-D-18-01138

Coronary interventions

Diagnostic Performance of Angiography-based Fractional Flow Reserve in Various Subgroups: Report from the FAST-FFR Study

Kobayashi Y, Collet C, Achenbach S, Engstrøm T, Assali A, Shlofmitz R, Fournier S, Kirtane A, Ali Z, Kornowski R, Leon M, De Bruyne B, Fearon W, Jeremias A, Greenberg G, Jubeh R, Lansky A, McAndrew T, Dressler O, Maehara A, Matsumura M

May 4, 2020 | 10.4244/EIJ-D-19-00933

Coronary interventions

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial

Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

December 6, 2019 | 10.4244/EIJ-D-19-00463

Coronary interventions

Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE Trial.

El Farissi M, Keulards D, van 't Veer M, Zelis JM, Berry C, De Bruyne B, Engstrøm T, Fröbert O, Piroth Z, Oldroyd K, Tonino P, Pijls N, Otterspoor L

September 10, 2019 | 10.4244/EIJ-D-19-00471

Coronary interventions

Qualitative resting coronary pressure wave form analysis to predict fractional flow reserve

Matsumura M, Maehara A, Johnson N, Fearon W, De Bruyne B, Oldroyd K, Pijls N, Jenkins P, Ali Z, Mintz G, Stone G, Jeremias A

February 7, 2019 | 10.4244/EIJ-D-17-01149

Stable CAD

Coronary lesion progression as assessed by fractional flow reserve (FFR) and angiography

Xaplanteris P, Ntalianis A, De Bruyne B, Strisciuglio T, Pellicano M, Ciccarelli G, Milkas A, Barbato E

October 19, 2018 | 10.4244/EIJ-D-17-00872

Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study

Svanerud J, Ahn J, Jeremias A, van 't Veer M, Gore A, Maehara A, Crowley A, Pijls N, De Bruyne B, Johnson N, Hennigan B, Watkins S, Berry C, Oldroyd K, Park S, Ali Z

September 20, 2018 | 10.4244/EIJ-D-18-00342

Coronary interventions

Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation

van’t Veer M, Adjedj J, Wijnbergen I, Toth G, Rutten M, Barbato E, Van Nunen L, Pijls N, De Bruyne B

August 20, 2016 | 10.4244/EIJV12I6A114

Interventions for valvular disease

Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve

Sawaya F, Kappetein A, Wisser W, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T

August 20, 2016

Coronary interventions

Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry

Iñiguez A, Brener S, Jimenez V, Maehara A, Mintz G, Xu K, Weisz G, Lansky A, De Bruyne B, Serruys P, Stone G

April 20, 2016 | 10.4244/EIJV11I13A285

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

Serruys P, Onuma Y, Garcia-Garcia H, Muramatsu T, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert K, Rapoza R, Ormiston J

March 20, 2014 | 10.4244/EIJV9I11A217

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

Gogas B, Bourantas C, Garcia-Garcia H, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns R, De Bruyne B, Chevalier B, Thuesen L, Smits P, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston J, Serruys P

October 25, 2013 | 10.4244/EIJV9I6A115

Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function

Di Serafino L, Pyxaras S, Mangiacapra F, Dierickx K, Toth G, Bartunek J, De Bruyne B, Van Mieghem C, Wijns W, Barbato E

March 22, 2013 | 10.4244/EIJV8I11A193

Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study

Ruiz-Garc J, Lerman A, Weisz G, Maehara A, Mintz G, Fahy M, Xu K, Lansky A, Cristea E, Farah T, Teles R, Bøtker H, Templin B, Zhang Z, De Bruyne B, Serruys P, Stone G

December 28, 2012 | 10.4244/EIJV8I8A142

A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial

Karjalainen P, Niemelä M, Airaksinen J, Rivero-Crespo F, Romppanen H, Sia J, Lalmand J, De Bruyne B, de Belder A, Carlier M, Nammas W, Ylitalo A, Hess O

July 27, 2012 | 10.4244/EIJV8I3A49

Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction

Mueller O, Delrue L, Hamilos M, Vercauteren S, Ntalianis A, Trana C, Mangiacapra F, Dierickx K, De Bruyne B, Wijns W, Behfar A, Barbato E, Terzic A, Vanderheyden M, Bartunek J

August 30, 2011 | 10.4244/EIJV7I4A75

Latest news

NEW ISSUE

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

EDITORIAL

Smoke signals – do they help to predict TAVI-associated stroke risk?

R. Kharbanda et al.

January 25, 2021

Trials Book

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

Last Week's JAA's: TTVr with the TriClip/MitraClip G4 System and much more...